Soligenix Q1 Revenue Surges to $1.06M

Ticker: SNGX · Form: 10-Q · Filed: May 9, 2025 · CIK: 812796

Soligenix, Inc. 10-Q Filing Summary
FieldDetail
CompanySoligenix, Inc. (SNGX)
Form Type10-Q
Filed DateMay 9, 2025
Risk Levelmedium
Sentimentbullish

Sentiment: bullish

Topics: revenue-growth, financials, 10-Q

TL;DR

Soligenix Q1 revenue up to $1.06M! Big jump from last year.

AI Summary

Soligenix, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported revenues of $1.06 million for the first quarter of 2025, a significant increase from $0.30 million in the same period of 2024. Total assets stood at $2.91 million as of March 31, 2025. The filing also references an Asset Purchase Agreement dated March 1, 2020.

Why It Matters

The substantial revenue growth indicates potential market traction for Soligenix's products or services, which could impact investor confidence and future valuation.

Risk Assessment

Risk Level: medium — While revenue growth is positive, the company's overall financial health and the sustainability of this growth require further analysis, typical for a pharmaceutical development stage company.

Key Numbers

  • $1.06M — Q1 2025 Revenues (Significant increase from Q1 2024)
  • $2.91M — Total Assets (As of March 31, 2025)
  • $0.30M — Q1 2024 Revenues (Comparison point for Q1 2025 growth)

Key Players & Entities

  • SOLIGENIX, INC. (company) — Filer
  • 20250331 (date) — Reporting Period End Date
  • $1.06 million (dollar_amount) — Q1 2025 Revenues
  • $0.30 million (dollar_amount) — Q1 2024 Revenues
  • $2.91 million (dollar_amount) — Total Assets as of March 31, 2025
  • 2020-03-01 (date) — Asset Purchase Agreement Date

FAQ

What were Soligenix's revenues for the first quarter of 2025?

Soligenix reported revenues of $1.06 million for the first quarter of 2025.

How do the Q1 2025 revenues compare to Q1 2024 revenues?

Q1 2025 revenues of $1.06 million represent a significant increase from $0.30 million in Q1 2024.

What was the total value of Soligenix's assets as of March 31, 2025?

As of March 31, 2025, Soligenix had total assets of $2.91 million.

Does the filing mention any significant agreements?

Yes, the filing references an Asset Purchase Agreement dated March 1, 2020.

What is the company's fiscal year end?

Soligenix, Inc.'s fiscal year ends on December 31.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 9, 2025 regarding SOLIGENIX, INC. (SNGX).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.